-
Borna S, Lee E, Sato Y, Bacchetta R. Towards Gene Therapy for IPEX Syndrome. European Journal of
Immunology. 2022 Mar 30. doi: 10.1002/eji.202149210.
-
Sato Y, Liu J, Lee E, Perriman R, Roncarolo MG, Bacchetta R. Co-expression of FOXP3FL and FOXP3d2
isoforms is required for optimal Treg-like cell phenotypes and suppressive function., Frontiers in
Immunology. 2021, 12:752394. doi: 10.3389/fimmu.2021.752394
-
Liu JM, Chen P, Uyeda MJ, Cieniewicz B, Sayitoglu EC, Thomas BC, Sato Y, Bacchetta
R, Cepika AM, Roncarolo MG. Pre-clinical development and molecular characterization of an engineered
type 1 regulatory T-cell product suitable for immunotherapy. Cytotherapy. Elsevier. Aug 15:
S1465-3249(21)00690-3. 2021
-
Sato Y, Passerini L, Piening BD, Uyeda MJ, Goodwin M, Gregori S, Snyder MP, Bertaina A, Roncarolo
MG, Bacchetta R. Human-engineered Treg-like cells suppress FOXP3-deficient T cells but preserve
adaptive immune responses in vivo. Clinical& Translational Immunology. Wiley. 9, e1214, 2020
-
Cepika A, Sato Y, Liu JM, Uyeda MJ, Bacchetta R, Roncarolo MG. Tregopathies: Monogenic diseases
resulting in regulatory T-cell deficiency. The Journal of allergy and clinical immunology142 (6),
1679?95, 2018
-
Kobayashi H, Ariga M, Sato Y, Fujiwara M, Fukasawa N, Fukuda T, et al. P-Tau and Subunit c
Mitochondrial ATP Synthase Accumulation in the Central Nervous System of a Woman with Hurler-Scheie
Syndrome Treated with Enzyme Replacement Therapy for 12 years. JIMD reports. 41, 101-107, 2018
-
Sato Y, Ida H, Ohashi T. Anti-BlyS antibody reduces the immune reaction against enzyme and enhances
the efficacy of enzyme replacement therapy in Fabry disease model mice. Clinical Immunology.
Elsevier. 178, 56-63, 2017
-
Sato Y, Kobayashi H, Higuchi T, Shimada Y, Ida H, Ohashi T. Metabolomic profiling of Pompe
disease-induced pluripotent stem cell-derived cardiomyocytes reveals that oxidative stress is
associated with cardiac and skeletal muscle pathology. Stem Cells Translational Medicine. Wiley.
6(1), 31-39, 2017
-
Sato Y, Kobayashi H, Higuchi T, Shimada Y, Ida H, Ohashi T. TFEB overexpression promotes glycogen
clearance of Pompe disease iPSC-derived skeletal muscle. Mol Ther Methods Clin Dev. NPG. 3, 16054,
2016
-
Limkul J, Iizuka S, Sato Y, Misaki R, Ohashi T, Ohashi T, Fujiyama K. The production of human
glucocerebrosidase in glyco-engineered Nicotiana benthamiana plants. Plant Biotechnology Journal.
Wiley. p1-13, 2016
-
Sato Y, Kobayashi H, Higuchi T, Shimada Y, Era T, Kimura S, Eto Y, Ida H, Ohashi T. Disease modeling
and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset
Pompe disease patient. Mol Ther Methods Clin Dev. NPG. 2, 15023, 2015
-
Sato Y, Fujiwara M, Kobayashi H, Yoshitake M, Hashimoto K, Oto Y, Ida H. Residual
glycosaminoglycan accumulation in mitral and aortic valves of a patient with
attenuated MPS I (Scheie syndrome) after 6 years of enzyme replacement therapy:
Implications for early diagnosis and therapy. Molecular Genetics and Metabolism
Reports. Elsevier. 5, 94-97, 2015
-
Sato Y, Kobayashi H, Shimada Y, Sato S, Fukuda T, Eto Y, Ohashi T, Ida H. Systemic
accumulation of undigested lysosomal metabolites in an autopsy case of
mucolipidosis type II; autophagic dysfunction in cardiomyocyte. Molecular Genetics
and Metabolism. Elsevier. 112(3), 224-228, 2014
-
Sato Y, Otsubo C, Wada Y, Kubo M, Ida H. Infantile Case of Pneumomediastinum
Complicated by Epidural Pneumatoisis. Elmer. International Journal of Clinical
Pediatrics. 3(1), 19-21, 2014
-
Sato Y, Fujiwara M, Kobayashi H, Ida H. Massive Accumulation of
Glycosaminoglycans in the Aortic Valve of a Patient With Hunter Syndrome During
Enzyme Replacement Therapy. Pediatr Cardiol. Springer. 34(8), 2077-9, 2013
|
